BEST Community Webinar

You’re Invited

An Introduction to the Opus Genetics Gene Therapy for Best Disease (Vitelliform Macular Dystrophy and Autosomal Recessive Bestrophinopathy)

  • Wednesday, November 11
  • 12:00 PM ET · 45 minutes
  • Live online · Free to attend
Register now

Join us for a free, live webinar for the Best disease community.

Wednesday, November 11 | 12:00 PM ETRegister now

Christine Kay, MD

Vitreo Retinal Associates

Gainesville, FL

Ben Shaberman

Ben Shaberman

Consulting LLC

What you’ll learn:

  • How gene therapy works
  • The road to a clinical trial and beyond
  • What we’ve learned so far from our ongoing BIRD-1 clinical trial
  • What comes next for our gene therapy and what this means for you

Have a question? Send it in when you register or during the session and we’ll answer as many as time allows.

OPGx-BEST1 is an investigational gene therapy. It has not been approved by the U.S. FDA or any other regulatory authority, and its safety and effectiveness have not been established. This webinar is for educational purposes only and is not medical advice.